Abstract
Background Following stroke, chronic cognitive impairments across multiple domains have been associated with depression. Currently, it is unknown if specific subtypes of cognitive impairments differentially relate to post-stroke depression severity. This study aimed to explore the differential associations between within-domain cognitive impairment to depression severity six-months after stroke.
Method Participants (n = 385, Age M = 73.86 years [SD = 12.51], National Institutes of Health Stroke Severity M = 6.83 [SD = 6.01]) were recruited from an acute stroke ward. Participants completed a self-report mood measure (Hospital Anxiety and Depression Scale; HADS) and a stroke-specific cognitive assessment (Oxford Cognitive Screen; OCS). Separate multiple regressions predicting depression were conducted across 1) OCS domain-specific cognitive impairments of language, memory, attention, praxis, numeracy and executive function, and 2) the novel subtask-specific impairments within each OCS domain. Anxiety severity and years of education attained were included as covariates.
Results Within-domain impairments that were uniquely associated with depression severity were calculation (b(.57) = 1.44, 95% CI [0.31, 2.56], p = .012), episodic memory (b(.52) = 1.36, 95% CI [0.34, 2.37], p = .009), picture naming (b(.45) = 1.18, 95% CI [0.31, 2.06], p = .008), number writing (b(.46) = 2.54, 95% CI [0.26, 2.07], p = .012), and visuospatial attention (b(.35) = 1.24, 95% CI [0.54, 1.93], p = .001). Analysis in pooled multiply imputed data (N = 430) corroborated complete case analysis findings.
Conclusions Specific within-domain cognitive impairments have differential relationships with post-stroke depressive symptomology. Accommodating for these impairments in post-stroke depression interventions may potentially enhance therapeutic outcomes.
Competing Interest Statement
Nele Demeyere is a developer of the Oxford Cognitive Screen but received no remuneration for its use.
Funding Statement
ND (Advanced Fellowship NIHR302224) and AK (DSE Award NIHR305153) are funded by NIHR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Research Ethics Committee of the Health Research Authority gave ethical approval for this work (REC ref: 18/SC/0550)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Joint last authorship
Data Availability
Data is freely available at https://www.dementiasplatform.uk/ and analysis code at https://osf.io/yrth4/
